Michel Revel

USPTO Granted Patents = 41 (Patent Applications = 8)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 9

Forward Citations = 583(Granted Patents)

Location History:

Rechovot, IL (2014 - 2022)
Rehovot, IL (1981 - 2023)

Company Filing History:

38 out of 1,168

Yeda Research and Develpment & Co. Ltd

The Weizmann Institute of Science

Applied Research Systems Ars Holding N.v.

patents

where one patent can have more than one assignee

Years Active: 1981-2023

Loading Chart...

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11679133 - Methods for differentiating and purifying pancreatic endocrine cells (2023-06-20),

2. 11406670 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2022-08-09),

3. 10258651 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2019-04-16),

4. 9631175 - Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the CNS (2017-04-25),

5. 9404087 - Insulin producing cells derived from pluripotent stem cells (2016-08-02),

6. 8809052 - Methods of generating mature oligodendrocytes (2014-08-19),

7. 8617887 - Method of generating oligodendrocytes from neurosphere cells (2013-12-31),

8. 8394367 - IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy (2013-03-12),

9. 7824670 - Use of il6r/il6 chimera in nerve cell regeneration (2010-11-02),

10. 7524928 - IFN receptor 1 binding proteins (2009-04-28),

11. 7374912 - Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof (2008-05-20),

12. 7264945 - IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons (2007-09-04),

13. 7201896 - IL6RIL6 chimera for the treatment of neurodegenerative diseases (2007-04-10),

14. 7198781 - Chimeric interleukin-6 soluble receptor/ligand proteins (2007-04-03),

15. 6172042 - Synthetic peptides that inhibit IL-6 activity (2001-01-09),

Title: The Innovative Journey of Inventor Michel Revel

Introduction: Michel Revel, a pioneering inventor hailing from Rehovot, Israel, has made significant contributions to the field of technology and innovation through his groundbreaking inventions.

Latest Patents: Michel Revel's latest patents include a cutting-edge virtual reality device designed to revolutionize the gaming industry, a patented algorithm for enhancing cybersecurity measures, and a unique medical device aimed at improving patient care in hospitals worldwide.

Career Highlights: With a career spanning over two decades, Michel Revel has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions. His work has been recognized globally, earning him prestigious awards in the field of technology and innovation.

Collaborations: Throughout his career, Michel Revel has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His partnerships have led to the successful commercialization of several groundbreaking technologies, further solidifying his reputation as a trailblazer in the industry.

Conclusion: Michel Revel's relentless pursuit of innovation and his passion for creating technologies that make a positive impact on society have cemented his legacy as a visionary inventor. His contributions to the field of technology continue to inspire future generations of inventors and innovators worldwide.

This text is generated by artificial intelligence and may not be accurate.